National guidelines for treatment of jaundice in the newborn

Acta Paediatrica, International Journal of Paediatrics

Volumn 100, Issue 4, 2011, Pages 499-505

  Bratlid, Dag ^a,b   Nakstad, B ^c,d   Hansen, T W R ^d,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Guidelines; Hyperbilirubinaemia; Newborn; Phototherapy

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD EXAMINATION; EXCHANGE BLOOD TRANSFUSION; EXTREMELY LOW BIRTH WEIGHT; FOLLOW UP; GESTATIONAL AGE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; LOW BIRTH WEIGHT; NEWBORN; NEWBORN JAUNDICE; NORWAY; PHOTOTHERAPY; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; TRANSCUTANEOUS BILIRUBINOMETRY; VERY LOW BIRTH WEIGHT;

EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTERNATIONALITY; JAUNDICE, NEONATAL; NORWAY; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC;

EID: 79952773067     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.02104.x     Document Type: Article

References (32)

1. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008; 358: 920-8. (Pubitemid 351397091)
2. Hansen TW, Bratlid D. Bilirubin and brain toxicity. Acta Paediatr Scand 1986; 75: 513-22. (Pubitemid 16100473)
3. Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med 2010; 15: 157-63.
4. Cremer RJ, Perryman PW, Richard DH. Influence of light on the hyperbilirubinemia of infants. Lancet 1958; 2: 1094-7.
5. Huizing K, Røislien J, Hansen T. Intravenous immunoglobulin reduces the need for exchange transfusion in Rhesus and AB0 incompatibility. Acta Paediatr 2008; 97: 1362-5.
6. Hansen TWR. Guidelines for treatment of neonatal jaundice. Is there a place for evidence-based medicine? Acta Paediatr 2001; 90: 239-41.
7. Skae MS, Moise J, Clarke P. Is current management of neonatal jaundice evidence based? Arch Dis Child 2005; 90: F540.
8. Watchko JF, Oski FA. Bilirubin 20 mg/dL = vigintiphobia. Pediatrics 1983; 71: 660-3.
9. Watchko JF. Vigintiphobia revisited. Pediatrics 2005; 115: 1747-53. (Pubitemid 43843186)
10. Bratlid D. Bilirubin toxicity: pathophysiology and assessment of risk factors. NYS J Med 1991; 91: 489-92.
11. Bratlid D. Criteria for treatment of neonatal hyperbilirubinemia. J Perinatol 1996; 16: 583-8.
12. Hansen TWR. Therapeutic approaches to neonatal jaundice: an international survey. Clin Pediatr 1996; 35: 309-16. (Pubitemid 26177176)
13. Rennie JM, Seghal A, De A, Kendall GS, Cole TJ. Range of UK practice regarding thresholds for phototherapy and exchange transfusions in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatal Ed 2009; 94: F323-7.
14. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol 1990; 17: 331-58.
15. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89: 809-18.
16. American Academy of Pediatrics Provisional Committee for Quality Improvement, Subcommittee on Hyperbilirubinemia. Practice parameter: management and of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94: 558-65.
17. American Academy of Pediatrics Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
18. Kaplan M, Merlob P, Regev R. Israeli guidelines for management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 2008; 28: 389-97. (Pubitemid 351780931)
19. Åkre B. Behandling av hyperbilirubinemi i nyfødtperioden. Tidsskr Nor Laegeforen 1974; 94: 716-9.
20. Bratlid D. Bestemmelse av fødselstermin med tidlig ultralydundersøkelse - galt, galere, galest? Tidsskr Nor Laegeforen 1991; 111: 1379-81.
21. Maisels MJ. Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation. Semin Fetal Neonatal Med 2010; 15: 129-35.
22. Bhutani V, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6-14. (Pubitemid 29281921)
23. Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 1969; 118: 454-8.
24. Maisels MJ, Watchko JF. Treatment of jaundice in low birth-weight infants. Arch Dis Child 2003; 88: 455-8.
25. Lo SF, Jendrzejczak B, Doumas BT. Laboratory performance in neonatal bilirubin testing using commutable specimens: a progress report on a College of American Pathologists study. Arch Pathol Lab Med 2008; 132: 1781-5.
26. Hansen TWR. Management of jaundice in the newborn nurseries - measuring, predicting and avoiding sequelae. Acta Paediatr 2009; 98: 1866-8.
27. Djokomuljanto S, Quah BS, Surini Y, Noraida R, Ismail NZN, Hansen TWR, et al. Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. Arch Dis Child 2006; 91: F439-42.
28. Mreihil K, McDonagh AF, Nakstad B, Hansen TWR. Early isomerization of bilirubin in phototherapy of neonatal jaundice. Pediatr Res 2010; 67: 656-9.
29. Meberg A, Johansen KB. Screening for neonatal hyperbilirubinemia and ABO alloimmunization at the time of testing for phenylketonuria and congentital hypothyreosis. Acta Paediatr 1998; 87: 1269-74. (Pubitemid 29001886)
30. Tønne A, Meberg A, Hager HB. Endring i diagnostikk og behandling av hyperbilirubinemi hos nyfødte. Tidsskr Nor Laegeforen 2010; 130: 18-20.
31. Macsic I, Trollebø AK, Bratlid D. Hyperbilirubinemia in a cohort of infants in a normal newborn nursery (NNN). Abstract A-268-0039-01763 EAP 2010.
32. Hansen TWR, Nietsch L, Norman E, Bjerre JV, Hascoet JM, Mreihil K, et al. Apparent reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr 2009; 98: 1689-94.